Comparative evaluation of intrathecal midazolam and low dose clonidine: efficacy, safety and duration of analgesia. A randomized, double blind, prospective clinical trial
- PMID: 22701246
- PMCID: PMC3371459
- DOI: 10.4103/0253-7613.96321
Comparative evaluation of intrathecal midazolam and low dose clonidine: efficacy, safety and duration of analgesia. A randomized, double blind, prospective clinical trial
Abstract
Background: The study was planned to assess the comparative efficacy, safety and duration of analgesia produced by low-dose clonidine and midazolam when used as adjuvant for spinal anesthesia.
Materials and methods: This is a randomized, participant and observer blind, prospective, parallel group clinical trial. Fifty ASA grade I and II patients posted for lower abdominal surgery were randomly allocated into two groups. BC group received spinal clonidine 30 μg and BM group received preservative-free midazolam 2 mg with 15 mg hyperbaric bupivacaine. Postoperative analgesia, analgesic requirement in 24 hours, onset and duration of block, hemodynamic stability and adverse effects were observed (P<0.05 - considered significant, P<0.01 considered highly significant).
Results: The duration of postoperative analgesia was prolonged in BM group (391.64 ± 132.98 min) than BC group (296.60 ± 52.77 min) (P<0.01). The mean verbal rating pain score was significantly less in BM group than BC group (P<0.01). The number of analgesic doses in 24 hours were significantly less in BM group (P<0.05). Nine patients (36%) in BC group required additional analgesia as against none in BM group (P<0.01). The onset of sensory block and peak sensory level was significantly earlier in BM group as compared to BC group. Duration of sensory block was longer in BM group (P<0.05). Subjects in BC group(36%) had bradycardia as compared to none in BM group (P<0.01). Hypotension was observed in 44% patients in BC group as against 16% in BM group (P<0.05).
Conclusion: Postoperative analgesia with clonidine is short lived with some bradycardia. Intrathecal midazolam provides superior analgesia without clinically relevant adverse effects.
Keywords: Spinal anesthesia; hyperbaric bupivacaine; intrathecal clonidine; intrathecal midazolam; lower abdominal surgery; postoperative analgesia.
Conflict of interest statement
References
-
- Duncan MA, Savage J, Tucker AP. Prospective audit comparing intrathecal analgesia (incorporating midazolam) with epidural and analgesia after major open abdominal surgery. Anaesth Intensive Care. 2007;35:558–62. - PubMed
-
- Saxena AK, Arava S. Current concepts in neuraxial administration of opioid and non-opioid: An overview and future perspectives. Indian J Anaesth. 2004;48:13–24.
-
- Kim MH, Lee YM. Intrathecal midazolam increased the analgesic effect of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. Br J Anaesth. 2001;86:77–9. - PubMed
-
- Gupta A, Prakash S, Deshpande S, Kale K. The effect of intrathecal midazolam 2.5 mg with hyperbaric bupivacaine on postoperative pain relief in patients undergoing orthopaedic surgry. Internet J Anesthesiol. 2007;14:11.
-
- Fogarty DJ, Carabine UA, Milligan KR. Comparison of the analgesic effects of intrathecal clonidine and intrathecal morphine after spinal anaesthesia in patients undergoing total hip replacement. Br J Anaesth. 1993;71:661–4. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
